European Union 
Co-financing from the state budget PRICE INQUIRY No. SEMA/13/2023/API - being conducted as a market assessment study
In connection with the implementation of the project titled “Design and development of an innovative solution – a generic drug of the GLP-1 receptor agonist class for the treatment of type 2 diabetes”,” funded from the state budget by the Medical Research Agency, WZA Polfa Warszawa S.A., you are kindly requested to submit a bid for the purchase and supply of the active pharmaceutical ingredient Semaglutide (C187H291N45O59, CAS 910463-68-2), described in detail in section III. Details of the price inquiry can be found in the documents attached below.
go back